NXLIW
Nexalin Technology, Inc.
Set alert
- YTD
- 0.00%
- 1 year
- 0.00%
- Open
- 0.012
- Prev close
- 0.0152
- Mkt cap
- 283.16K
- Vol
- 122.67K
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.0093
- High
- 0.0138
- Forward P/E
- 0.00
- Beta
- 3.57
- Short ratio
- 0.00
- Inst. own
- 0.00%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 0.00
- 200-d avg
- 0.00
- 1y target
- 0.00
Key statistics
- Market cap
- 0
- Enterprise value
- 0
- Trailing P/E
- 0.00
- Forward P/E
- 0.00
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 1.08
- EPS (TTM)
- 0.00
- Beta
- 3.57
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 0.00%
- Revenue (TTM)
- 150.16K
- Revenue growth
- -24.50%
- Free cash flow
- -1.75M
- Total cash
- 848.80K
- Total debt
- 0
- Return on equity
- -202.23%
- Shares outstanding
- 0
- Short % of float
- 0.00%
- 50-day average
- 0.00
- 200-day average
- 0.00
Analyst view
Consensus: none
Next earnings
Consensus EPS estimate 0.00.
About Nexalin Technology, Inc.
Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China. The company designs and develops Generation 2 and Generation 3, that is in clinical trials for the treatment of substance abuse issues related to opiate, cocaine, alcohol abuse, alzheimer's disease, and dementia. It also licenses and sells Nexalin Device, a non-invasive and undetectable to the human body that can provide relief to its afflicted with mental health issues. The company is based in Houston, Texas.
- Sector
- Healthcare
- Industry
- Medical Devices
- Country
- United States
- Website
- nexalin.com
News
No recent headlines
Headlines appear here as they are published.
Your note
Sign in to keep a note on NXLIW — it syncs with the Stock Master app.
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Clear Street LLC | 20.09% | 326,454 | 152.06K | Sep 29, 2024 |
| Armistice Capital, LLC | 20.00% | 325,000 | 151.38K | Sep 29, 2024 |
| Warberg Asset Management LLC | 9.31% | 151,272 | 70.46K | Sep 29, 2024 |
| Citadel Advisors Llc | 9.21% | 149,632 | 69.70K | Sep 29, 2024 |
| Altium Capital Management, LP | 6.46% | 105,000 | 48.91K | Sep 29, 2024 |
| UBS Group AG | 1.28% | 20,742 | 9.66K | Sep 29, 2024 |